{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:17:02Z","timestamp":1782728222131,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/bmt.2014.256","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T18:19:02Z","timestamp":1417457942000},"page":"221-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan"],"prefix":"10.1038","volume":"50","author":[{"given":"N","family":"Yasui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"BFbmt2014256_CR1","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/cncr.11647","volume":"98","author":"CB Antoneli","year":"2003","unstructured":"Antoneli CB, Steinhorst F, de C\u00e1ssia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V et al. Extraocular retinoblastoma: a 13-year experience. Cancer 2003; 98: 1292\u20131298.","journal-title":"Cancer"},{"key":"BFbmt2014256_CR2","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/S0959-8049(97)10019-3","volume":"33","author":"F Namouni","year":"1997","unstructured":"Namouni F, Doz F, Tanguy ML, Quintana E, Michon J, Pacquement H et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 1997; 33: 2368\u20132375.","journal-title":"Eur J Cancer"},{"key":"BFbmt2014256_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.bmt.1703832","volume":"31","author":"B Kremens","year":"2003","unstructured":"Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003; 31: 281\u2013284.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014256_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.bmt.1704882","volume":"35","author":"H Matsubara","year":"2005","unstructured":"Matsubara H, Makimoto A, Higa T, Kawamoto H, Sakiyama S, Hosono A et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant 2005; 35: 763\u2013766.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014256_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/pbc.24280","volume":"60","author":"DN Friedman","year":"2013","unstructured":"Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP et al. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Pediatr Blood Cancer 2013; 60: 694\u2013699.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2014256_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/bmt.2011.108","volume":"47","author":"J Palma","year":"2012","unstructured":"Palma J, Sasso DF, Dufort G, Koop K, Sampor C, Diez B et al. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America. Bone Marrow Transplant 2012; 47: 522\u2013527.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014256_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5144\/1658-3876.2012.107","volume":"5","author":"I Jaradat","year":"2012","unstructured":"Jaradat I, Mubiden R, Salem A, Abdel-Rahman F, Al-Ahmad I, Almousa A . High-dose chemotherapy followed by stem cell transplantation in the management of retinoblastoma: a systematic review. Hematol Oncol Stem Cell Ther 2012; 5: 107\u2013117.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"BFbmt2014256_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","volume":"6","author":"F Berthold","year":"2005","unstructured":"Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol 2005; 6: 649\u2013658.","journal-title":"Lancet Oncol"},{"key":"BFbmt2014256_CR9","doi-asserted-by":"crossref","unstructured":"Ladenstein RL, Poetschger U, Luksch R, Brock P, Castel V, Yaniv I et al. Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: results from the HR-NBL1\/SIOPEN trial. J Clin Oncol 2011; 29 (Suppl) abstract 2.","DOI":"10.1200\/jco.2011.29.18_suppl.2"},{"key":"BFbmt2014256_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08880010390158829","volume":"20","author":"H Matsubara","year":"2003","unstructured":"Matsubara H, Makimoto A, Higa T, Kawamoto H, Takayama J, Ohira M et al. Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy. Pediatr Hematol Oncol 2003; 20: 201\u2013210.","journal-title":"Pediatr Hematol Oncol"},{"key":"BFbmt2014256_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.bmt.1702376","volume":"25","author":"D Valteau-Couanet","year":"2000","unstructured":"Valteau-Couanet D, Benhamou E, Vassal G, Stambouli F, Lapierre V, Couanet D et al. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplant 2000; 25: 937\u2013942.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014256","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:13:53Z","timestamp":1648059233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFbmt2014256"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.256","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]},"assertion":[{"value":"15 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}